Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. McNamara, M. Sachs, S. Landvik, M. Smieja, J. Majkozak, L. Read, L. Gandrud (Minneapolis, United States Of America). Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD). Eur Respir J 2012; 40: Suppl. 56, 1113

Member's Comments

No comment yet.

Related content which might interest you: Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003 Cystic fibrosis related diabetes (CFRD) and diabetic control as a determinant of pulmonary function: fact or fiction? Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Audit of management of pseudomonas aeruginosa infection in children with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Peculiarities of diabetes mellitus in cystic fibrosis adults Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Pseudomonas aeruginosa (Pa) antibiotic resistance (AR): Comparison in adults and children with cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 To improvement of diagnostics of the diabetes mellitus 2 type at patients with chronic obstructive pathology of lungs Source: International Congress 2014 – COPD: points to ponder Year: 2014 Stenotrophomonas maltophilia and achromobacter xylosoxidans in cystic fibrosis patients Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 COVID-19: Impact in adult patients with premorbid disease: Metabolic diseases (diabetes, obesity) Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=234 Year: 2006 Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Lung function in children with juvenile diabetes type 1 Source: Eur Respir J 2002; 20: Suppl. 38, 139s Year: 2002 Evaluation of disease knowledge in children with cystic fibrosis and their families Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 The study of expectant life of St-Petersburg patients with cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 617s Year: 2004 New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis Source: Eur Respir J 2005; 25: 715-717 Year: 2005 p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Late Breaking Abstract - The cost, health resources utilization and medications in chronic obstructive pulmonary patients with diabetes mellitus: a population-based cohort study in Taiwan. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Epidemiology and factors associated with overweight in adults with cystic fibrosis: an Italian multicenter experience. Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Feasibility study of an intervention to increase treatment adherence in children with cystic fibrosis (CF) Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019